The BDD technology worked EXACTLY as advertised. The BDD pill is ready to be used in it's current and tested oral form in a soon to be $48B IBD market. IMO BDD can tweak their technology to deliver Brilacidin to ANY targeted area in the GI tract for IBD or any other indication.
One of the pesky hard bashers kept repeating the same lie that only 4/9 targeted areas worked on the Phase1 trial. We now know that this alias was spewing lies so the criminals will have to try to make up new lies. Moderators will continue to delete the hard basher BS.
(12)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links